Treatment of severe recurrent hepatitis C after liver transplantation in HIV infected patients using sofosbuvir-based therapy-Reference-Cited by-同舟云学术

Treatment of severe recurrent hepatitis C after liver transplantation in HIV infected patients using sofosbuvir-based therapy

Published:2016-04-21 Issue:12 Volume:43 Page:1319-1329
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Campos-Varela I.¹²³,Moreno A.⁴,Morbey A.⁵,Guaraldi G.⁶,Hasson H.⁷,Bhamidimarri K. R.⁸,Castells L.⁹¹⁰,Grewal P.¹¹,Baños I.¹²,Bellot P.¹³¹⁴,Brainard D. M.¹⁵,McHutchison J. G.¹⁵,Terrault N. A.³

Affiliation:

1. Universidade de Santiago de Compostela (CLINURSID); Santiago de Compostela Spain

2. Hospital of Santiago de Compostela; Santiago de Compostela Spain

3. University of California-San Francisco; San Francisco CA USA

4. Hospital Ramón y Cajal; Madrid Spain

5. Hospital Curry Cabral; Lisbon Portugal

6. Clinic of Infectious Diseases; University of Modena and Reggio Emilia; Modena Italy

7. Scientific Institute Ospedale San Raffaele; Milan Italy

8. Division of Hepatology; University of Miami-Miller School of Medicine; Miami FL USA

9. CIBERehd; Instituto de Salud Carlos III; Barcelona Spain

10. Hospital Universitario Vall d'Hebron; Barcelona Spain

11. Mount Sinai School of Medicine; New York NY USA

12. Hospital Universitario Puerta de Hierro; Madrid Spain

13. CIBERehd; Instituto de Salud Carlos III; Madrid Spain

14. Hospital General Universitario; Alicante Spain

15. Gilead Sciences; Foster City CA USA

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.13629/fullpdf

Reference23 articles.

1. Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection;Terrault;Liver Transpl,2012

2. Outcome of HCV/HIV-coinfected liver transplant recipients: a prospective and multicenter cohort study;Miro;Am J Transplant,2012

3. Peginterferon and ribavirin for treatment of recurrent hepatitis C disease in HCV-HIV coinfected liver transplant recipients;Terrault;Am J Transplant,2014

4. Pegylated interferon plus ribavirin in HIV-infected patients with recurrent hepatitis C after liver transplantation: a prospective cohort study;Castells;J Hepatol,2015

5. A US multicenter study of hepatitis c treatment of liver transplant recipients with protease-inhibitor triple therapy;Burton;J Hepatol,2014

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of directly acting antiviral drugs in HCV patients with HIV in liver transplantation: A meta-analysis;Decoding Infection and Transmission;2023

2. Nonviral liver disease is the leading indication for liver transplant in the United States in persons living with human immunodeficiency virus;American Journal of Transplantation;2021-07-08

3. Living donor domino liver transplantation in a hepatitis C virus/human immunodeficiency virus-coinfected hemophilia patient: a case report;Surgical Case Reports;2020-07-29

4. Temporal Trends and Outcomes in Liver Transplantation for Recipients With HIV Infection in Europe and United States;Transplantation;2019-12-31

5. Consensus on management of hepatitis C virus infection in resource-limited Ukraine and Commonwealth of Independent States regions;World Journal of Gastroenterology;2019-08-07